Rhythm Pharmaceuticals Inc (RYTM) - News Archive

Rhythm Pharmaceuticals Grants Employment Inducement Equity to Drive Growth and InnovationSummary:Rhythm Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in rare neuroendocrine diseases, has ann...

Rhythm Pharmaceuticals, a leading biopharmaceutical company dedicated to improving the lives of patients and families facing rare neuroendocrine diseases, recently announced the issuance of employment inducement grants...

In an exciting development in the field of metabolic disorders, Rhythm Pharmaceuticals has recently entered into an agreement with LG Chem Life Sciences to acquire global rights to the oral MC4R agonist LB54640. This no...

Rhythm Pharmaceuticals Grants New Inducement Equity to Drive Growth and InnovationIn a recent press release, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in rare melanocortin-4 receptor pathway disea...